FRM
BIO icon

Fox Run Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fox Run Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,122
Closed -$1.03M – 924
2024
Q4 		$1.03M Buy
+3,122
New +$1.06M 0.19% 149

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fox Run Management's BIO Position: Q1 2025 in Review

Fox Run Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 3,122 shares — an estimated $1.03M sold.

Fox Run Management first reported a position in BIO in Q4 2024 and held it in 1 quarter. The position peaked at $1.03M in Q4 2024. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Fox Run Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 3,122 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $1.03M.
  • Fox Run Management first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 1 quarter.
  • Fox Run Management's Bio-Rad Laboratories Class A position peaked at $1.03M in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.